Seven years: This is the average time required to diagnose endometriosis. Yet, this chronic disease affects 1 in 10 women. In addition, 30 to 40% of women with endometriosis experience fertility problems.
Endometriosis is a chronic inflammatory disease: the inner wall of the uterus, the endometrium, thickens to eventually accommodate a fertilized embryo. But if nothing happens, then it decomposes in abnormal places. Three main symptoms can then be suggestive of the disease:
In addition to disabling pain, lesions and infertility, other symptoms should be monitored such as difficulty urinating, digestive disorders (diarrhea or constipation) or chronic fatigue.
Today, the therapeutic arsenal available to women with endometriosis includes drugs, surgery and medically assisted reproduction (MAC) in the event of a planned pregnancy.
Hormonal contraception is the first treatment tested for endometriosis that occurs only during menstruation. Among the options available are the various contraceptive pills, but also the vaginal ring, the etonogestrel implant or the levonorgestrel coil. If these drugs work well, they can work against painful periods but also pain during sexual intercourse (dyspareunia) and pelvic pain. The other hormonal solution is often referred to as “artificial menopause”. These are GN-Rh agonist drugs, prescribed if contraception has failed or when medical procreation assistance (MPA) is requested.
If medication is not enough, surgery may be offered, depending on the location of the lesions and their severity. Again, a precise exchange is necessary, due to the risks of the intervention and possible side effects. When only the lesions are operated on, we speak of conservative surgery. This means that the reproductive organs, bladder or rectum will not be affected.
It is estimated that 40 to 50% of women with endometriosis also suffer from infertility, although this association cannot really be explained. Patients can then access the different techniques of medically assisted reproduction (MPA). The results are rather positive: more than one woman in four gives birth at the first IVF. Moreover, before surgery, oocyte storage is often proposed.
The earlier the disease is detected, the better the quality of life of those affected.
EVADEO PRO supports you in the diagnosis and treatment of this pathology and assists you in your care journey as part of a complete health check-up, during a medical evacuation or a medical stay for the treatment of this disease.
And because Evadeô Pro appears as the leader in medical tourism in France, we also offer you to enhance your stay by selecting among our services at a preferential price, those that correspond to your desires or your needs…
Ask to be called back, or contact us by phone or email to tell us your needs; our team will do the rest!
Evadêo Pro – Leader in healthcare stays and medical tourism in France.